Walleye Trading LLC Acadia Pharmaceuticals Inc Transaction History

Walleye Trading LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $196,250 - $315,186	9,417 New	9,417 $196,000
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $86,904 - $111,399	5,325 Added 41.81%	18,061 $339,000
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $148,929 - $195,391	-10,488 Reduced 45.16%	12,736 $202,000
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $264,449 - $342,416	18,742 Added 418.16%	23,224 $380,000
Q2 2022 Aug 08, 2022	SELL	$13.01 - $27.22 $180,721 - $378,113	-13,891 Reduced 75.61%	4,482 $63,000
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $227,743 - $299,090	-10,876 Reduced 37.18%	18,373 $445,000
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $163,601 - $263,964	-9,744 Reduced 24.99%	29,249 $683,000
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $320,207 - $502,632	20,292 Added 108.51%	38,993 $648,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $179,935 - $254,320	9,275 Added 98.4%	18,701 $456,000
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $209,445 - $414,838	9,426 New	9,426 $339,000
Q3 2017 Nov 14, 2017	SELL	$29.49 - $38.37 $9,967 - $12,969	-338 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	338	338 $9,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.